{"id":"W2565314365","doi":"10.1016/j.ahj.2016.12.004","title":"The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial","year":2016,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary","funders":"Portola Pharmaceuticals","keywords":"Medicine; Deep vein; Thrombosis; Pulmonary embolism; Dosing; Population; Cohort; Asymptomatic; Relative risk; Surgery; Anesthesia; Internal medicine; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002431561,0.0007743587,0.002182374,0.0001376565,0.0002442028,0.001508263,0.0006612751,0.0008224004,0.002641045],"category_scores_gemma":[0.003467283,0.0003168481,0.001570229,0.0002210666,0.0008995681,0.001127073,0.0005609666,0.002995845,0.0002867198],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005046569,"about_ca_system_score_gemma":0.0006027541,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004989157,"about_ca_topic_score_gemma":0.0006896802,"domain_scores_codex":[0.9988158,0.0007591632,0.00007313347,0.0001517204,0.0000870347,0.0001132295],"domain_scores_gemma":[0.9980652,0.0008981561,0.0003741207,0.0002528945,0.00007282665,0.0003369544],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.977895,0.0009515944,0.0025635,0.0002807119,0.001872678,0.00006374434,0.00005720696,0.0006052929,0.001317471,0.0003608585,0.0003661914,0.01366577],"study_design_scores_gemma":[0.8852693,0.07799321,0.02441122,0.0001376826,0.005413777,0.0002440854,0.0001722144,0.002270765,0.001121789,0.001537953,0.001359458,0.00006850557],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943935,0.003154254,0.0002638459,0.0004278758,0.0001707877,0.00009148486,0.0002417682,0.00001518951,0.001241347],"genre_scores_gemma":[0.9959039,0.001524342,0.0004770885,0.0006036047,0.0002513918,0.00009140844,0.0004150913,0.000008599186,0.0007245143],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002641045,"threshold_uncertainty_score":0.01285946,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02045808003179508,"score_gpt":0.3213429566568022,"score_spread":0.3008848766250071,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}